RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Sanofi Ventures
S

Sanofi Ventures portfolio

Sanofi Ventures has 22 portfolio companies on record at Recent Funding, with 7 investments in the last 12 months.

Type: Corporate venture.
Portfolio on Recent Funding: 22.
Deals, last 12 months: 7.
Rounds led: 8 of 26.
Capital in their rounds: $3.2B.
Latest deal: T-Therapeutics · Nov 5, 2026.
About this page

It is a corporate venture investor based in Cambridge, US, founded in 2001. It led 8 of the 26 rounds it joined. Its most recent investment on record is T-Therapeutics's $133M Series B+ round in November 2026, alongside Digitalis Ventures, Cambridge Innovation Capital, Johnson & Johnson Innovation and 6 others. By category, its portfolio leans toward Health and bio (22) and Education (1). It has co-invested with Samsara Biocapital, Sofinnova Partners and Digitalis Ventures, most often Samsara Biocapital (7 rounds).

About Sanofi Ventures

Firm type: Corporate venture.
Headquarters: Cambridge, US.
Founded: 2001.
Stages: Seed, Series A, Series B.
Sectors: AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices.
Leads rounds: Yes.
Portfolio companies: 119.
Exits: 8.
Rounds led: 15.

What Sanofi Ventures invests in

Sanofi Ventures recent investments

How Sanofi Ventures invests

StageDealsCapital in rounds
Series B+ 16 62%$2.15B
Series A 9 35%$1.03B
Seed 1 4%$17M
YearDealsCapital in rounds
2021 4 15%$127M
2022 3 12%$265M
2023 2 8%$214M
2024 2 8%$468M
2025 8 31%$897M
2026 7 27%$1.23B

Sanofi Ventures portfolio companies

CompanyRound with Sanofi VenturesTotal raisedLatest raise
TT-Therapeutics
Health and bio
Series B+ · $133M$283MNov 5, 2026
Series B+
OOMass Therapeutics
Health and bio
Series B+ · $310M$422.51MOct 15, 2026
Series B+
MMatchpoint Therapeutics
Health and bio
Series B+ · $150M$250MOct 7, 2026
Series B+
AAbcuro
Health and bio
Series B+ · $66M$463MAug 18, 2026
Series B+
EEpicrispr Biotechnologies
Health and bio
Series B+ · $90M$158MAug 11, 2026
Series B+
AAdvanCell
Health and bio
Series B+ · $315M$439.5MJul 15, 2026
Series B+
BBionyra
Health and bio
Series A · $165M$165MJun 22, 2026
Series A
SStar Therapeutics
Health and bio
Series B+ · $125M · lead$415MOct 23, 2026
Series B+
SSplice Bio
Health and bio
Series B+ · $140M · lead$197MJun 11, 2025
Series B+
TTherini Bio
Health and bio
Series A · $39M$56MMay 21, 2026
Series A
GGlycomine
Health and bio
Series B+ · $115M$195MMay 9, 2025
Series B+
NNormunity
Health and bio
Series B+ · $75M$140MJan 13, 2025
Series B+
NNura Bio
Health and bio
Series A · $68M$141.8MJun 22, 2026
Series B+
MMirador Therapeutics
Health and bio
Series A · $400M$650MJan 13, 2026
Series B+
CClick Therapeutics
Health and bio
Series B+$50MApr 13, 2026
Series B+
DDraig Therapeutics
Health and bio
backer$205MJul 14, 2026
Series B+
ZZag Bio
Health and bio
backerundisclosed—
CCharacter Bio
Health and bio
backer$111MMar 25, 2025
Series B+
LLifordi Immunotherapeutics
Health and bio
backerundisclosedNov 18, 2025
Series A
GGranite Bio
Health and bio
backer$30MApr 25, 2025
Series A
CCurevo Vaccine
Health and bio
backerundisclosedMar 18, 2025
Series B+
WWindward Bio
Health and bio
backer$200MMay 5, 2026
round

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 26 rounds on Recent Funding that name Sanofi Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Sanofi Ventures, which is a subset of its real portfolio. API: /api/v1/investors/sanofi-ventures (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy